60
Participants
Start Date
April 9, 2023
Primary Completion Date
April 8, 2025
Study Completion Date
April 8, 2026
Blood and nasal swab sampling
Genetic screening of DNA samples (blood, mucosal swab, brain tissue) from 60-100 patients with histologically confirmed diagnosis of FCDIIA/B identified from Epilepsy Surgery Databases.
RECRUITING
King's College Hospital, London
King's College London
OTHER
Danish Epilepsy Centre
UNKNOWN
King's College Hospital NHS Trust
OTHER